Health News StoriesExcerpts of Key Health News Stories in Major Media
Note: This comprehensive list of health news stories is usually updated once a week. Explore our full index to revealing excerpts of key major media news stories on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.
According to a July 17 study published in the International Journal of Geriatrics and Rehabilitation, 50 percent of nucleic acid coronavirus tests distributed by the Centers for Disease Control and Prevention (CDC) provided inaccurate results. The study's lead author, Sin Hang Lee, MD, director of Milford Molecular Diagnostics Laboratory, found that the testing kits gave a 30 percent false-positive rate and a 20 percent false-negative rate. To determine these false-positive and false-negative rates, the Connecticut State Department of Public Health Microbiology Laboratory provided Lee 20 tests, which were then re-tested using his own methodology, which examines samples on a cellular level, rather than just testing fluid with no cellular matter from potentially infected oral and nasal secretions. While the results of Lee's testing may be alarming, they also pointed to yet another discovery: new mutations of the virus. Two tests that initially provided false-negatives and one test that yielded a positive result were actually found to be positive for coronavirus and a mutation of the virus, meaning two variants of the virus can simultaneously infect one person. However, it's not just the test you use that may be contributing to inaccurate results—when you get tested is important, too. Getting tested the day a person is infected with coronavirus will likely yield a 100 percent false-negative rate; by day 8 after becoming infected, however, that rate drops to just 20 percent.
Note: For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.
Sweden famously took a totally different approach to its Nordic neighbours in trying to contain the spread of the novel coronavirus. The Swedish strategy allowed people to keep living largely as normal. Stores and restaurants remained open – so too did many schools. With a COVID-19 death toll of 5,700, Sweden’s mortality rate from the disease is now around a quarter higher than that of the United States, when adjusted for population size. However, authorities insist that the number of deaths has considerably dropped in recent weeks. "We've actually seen a clearly declining trend in the number of patients in intensive care and also in the number of deaths since the middle of April," said Anna Mia Ekström ... at Stockholm’s Karolinksa Institute. So how close is Sweden to possibly reaching herd immunity? We don’t know at this point. Scientists are still trying to figure out whether immunity from the new coronavirus can even be reached – and for how long. Ekström noted that the reproduction number of the epidemic – or R number, which measures the average number of people that one infected person will pass the virus on to – has now fallen in Sweden to around 0.6, meaning transmission is declining. The number of people with antibodies against the new coronavirus, meanwhile, is increasing. Data published by Sweden’s public health agency in June showed that about 10 per cent of people in Stockholm – the nation's worst affected area – had developed antibodies to COVID-19, more than anywhere else in the country.
Note: The number of new cases and deaths in Sweden has dropped significantly while the U.S. other non-European countries are seeing a rise in both, according to this MSN article. For the month of July 2020, Sweden had 370 deaths while California had 3,200 deaths. California has a population about four times that of Sweden, yet California with its strict lockdown had almost 10 times as many deaths as Sweden, which is one of the few countries that chose not to lock down. For more, see concise summaries of revealing news articles on the coronavirus from reliable major media sources.
Pandemics can be indiscriminate. COVID-19 has been different. The disease has shown a special animus for older people, with those 65-plus considered at especially high risk for hospitalization and death, and those 18 and below catching a semblance of an epidemiological break. Adolescents ... are likelier to experience milder symptoms or none at all. But if COVID-19 is sparing most kids’ bodies, it’s not being so kind to their minds. In one study out of China, published in JAMA Pediatrics, researchers in Hubei province, where the pandemic originated, examined a sample group of 2,330 schoolchildren for signs of emotional distress. The kids had been locked down for ... an average of 33.7 days. 22.6% of them reported depressive symptoms and 18.9% were experiencing anxiety. Then too there is ... the economy, which continues to struggle badly. A 2018 paper published in Health Economics ... studied economic conditions in the U.S. from 2001 to 2013 and found that during the Great Recession, a 5-percent-age-point increase in the national unemployment rate correlated with an astounding 35% to 50% increase in “clinically meaningful childhood mental-health problems.” With unemployment now exceeding 11%, [health-policy researcher Ezra] Golberstein expects to see more of the same emotional blowback. “When the economy is in a bad place, kids’ mental health gets worse,” he says. “Children who were struggling before [the pandemic] are at higher risk now,” says psychologist Robin Gurwitch.
Note: For the second quarter of 2020, the U.S. GDP plunged 32.9% according to this CNBC article. The lockdown policies are clearly damaging not only the health of the economy, but of the children as well. For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus and health from reliable major media sources.
Mounting evidence suggests the coronavirus is more common and less deadly than it first appeared. The evidence comes from tests that detect antibodies to the coronavirus in a person's blood rather than the virus itself. The tests are finding large numbers of people in the U.S. who were infected but never became seriously ill. And when these mild infections are included in coronavirus statistics, the virus appears less dangerous. "The current best estimates for the infection fatality risk are between 0.5% and 1%," says Caitlin Rivers, an epidemiologist at the Johns Hopkins Center for Health Security. That's in contrast with death rates of 5% or more based on calculations that included only people who got sick enough to be diagnosed with tests that detect the presence of virus in a person's body. And the revised estimates support an early prediction by Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases. In an editorial published in late March ... Fauci and colleagues wrote that the case fatality rate for COVID-19 "may be considerably less than 1%." The new evidence is coming from places such as Indiana, which completed the first phase of a massive testing effort early in May. Indiana's infection fatality rate turned out to be about 0.58%, or roughly one death for every 172 people who got infected. In New York ... an antibody study indicated the state has an infection fatality rate around 0.5%. Studies in Florida and California have suggested even lower fatality rates.
Note: For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.
Research shows that acts of kindness make us feel better and healthier. Kindness is also key to how we evolved and survived as a species, scientists say. We are hard-wired to be kind. Psychology professor Sonja Lyubomirsky has put that concept to the test in numerous experiments over 20 years and repeatedly found that people feel better when they are kind to others, even more than when they are kind to themselves. “Acts of kindness are very powerful,” Lyubomirsky said. In one experiment, she asked subjects to do an extra three acts of kindness for other people a week and asked a different group to do three acts of self-kindness. The people who were kind to others became happier and felt more connected to the world. The same occurred with money, using it to help others versus helping yourself. Lyubomirsky said she thinks it is because people spend too much time thinking and worrying about themselves and when they think of others while doing acts of kindness, it redirects them away from their own problems. Oxford’s [Oliver] Curry analyzed peer-reviewed research like Lyubomirsky’s and found at least 27 studies showing the same thing: Being kind makes people feel better emotionally. But it’s not just emotional. It’s physical. Lyubomirsky said a study of people with multiple sclerosis ... found they felt better physically when helping others. She also found that in people doing more acts of kindness that the genes that trigger inflammation were turned down more than in people who don’t.
One by one, vaccine developers at a White House roundtable convened by President Donald Trump in early March pitched their product as a viable solution to the coronavirus. Stéphane Bancel of Moderna Inc. glanced across the table at the nation's top infectious disease expert, Dr. Anthony Fauci, and said he is "very proud to be working with the US government and to have already sent, in only 42 days from the sequence of the virus, our vaccine to Dr. Fauci's team at the NIH." Bancel went on to say that he needed just "a few months" to start phase two of a three-part clinical trial of the sort that typifies vaccine development. (The entire process often takes more than a decade.) The day after the roundtable, the FDA green-lit Moderna's product for trial, making it the first vaccine candidate to advance to the first phase of a clinical study, in which an as-yet unapproved vaccine is injected into the arms of a small group of 45 human volunteers. The effort received another boost on April 16, when the federal Biomedical Advanced Research and Development Authority (BARDA) awarded Moderna up to $483 million to accelerate the development and manufacturing of the vaccine. The FDA allowed Moderna's RNA vaccine ... to essentially gloss over the animal-testing that typically precede clinical trials in humans. [Moderna's former director of chemistry Dr. Suhaib] Siddiqi said this is cause for alarm. "I would not let that [vaccine] be injected in my body," he said. "I would demand: Where is the toxicity data from the lab?"
Note: Read a New York Times/MSN article titled "Corporate Insiders Pocket $1 Billion in Rush for Coronavirus Vaccine." For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus and vaccines from reliable major media sources.
The drug that buoyed expectations for a coronavirus treatment and drew international attention for Gilead Sciences, remdesivir, started as a reject. To make progress, Gilead needed help from U.S. taxpayers. Lots of help. Three federal health agencies were deeply involved in remdesivir’s development every step of the way, providing tens of millions of dollars of government research support. Federal agencies have not asserted patent rights to Gilead’s drug. That means Gilead will have few constraints other than political pressure when it sets a price. “Without direct public investment and tax subsidies, this drug would apparently have remained in the scrapheap of unsuccessful drugs,” Rep. Lloyd Doggett (D-Tex.) ... said earlier this month. Doggett and Rep. Rosa L. DeLauro (D-Conn.) have asked Health and Human Services Secretary Alex Azar for a detailed financial accounting of federal support for remdesivir’s discovery and development. Watchdog groups ... have documented the large taxpayer-funded contributions toward the drug. Public Citizen estimates public investment at a minimum of $70 million. An independent organization that measures the cost-effectiveness of drugs said Gilead could be justified in charging up to $4,500 for a 10-day course of treatment for a single coronavirus patient. But advocates, citing a study by academic researchers on what it costs to make the drug, have said Gilead could break even by charging $1 per dose.
Note: According to this CNBC article Gilead is charging from $2,000 to $3,120 per patient despite huge subsidies. Gilead is the same company which developed Tamiflu and licensed it to Roche. Aggressive sales of Tamiflu to governments around the world brought profits of over $1 billion yet almost none of the doses sold were ever used, as described in this Reuters article. The study that is being used to tout Remdesivir was conducted by none other than Gilead. Could there be conflict of interest here? For more, see summaries of revealing news articles on big Pharma corruption.
Pediatricians say students should be in classrooms for in-person learning as soon as possible – the most full-throated endorsement yet for getting children back into schools amid the coronavirus pandemic and one that was included in a set of recommendations released by the American Academy of Pediatrics for how schools should safely reopen. "The importance of in-person learning is well-documented, and there is already evidence of the negative impacts on children because of school closures in the spring of 2020," the group representing 67,000 pediatricians wrote. "Lengthy time away from school ... often results in social isolation, making it difficult for schools to identify and address important learning deficits as well as child and adolescent physical or sexual abuse, substance use, depression, and suicidal ideation. This, in turn, places children and adolescents at considerable risk of morbidity and, in some cases, mortality." The recommendations acknowledge that infectious disease experts are still learning about the effects of COVID-19. But the academic, physical and mental upsides associated with reopening outweigh the risks, the group concludes, especially as evidence mounts that children ... tend to exhibit milder symptoms when they do contract the virus. Perhaps most importantly, the pediatric group concludes, reopening is essential for the country's most vulnerable students, including poor students and students of color.
Note: For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.
Sweden’s decision to keep schools open during the pandemic resulted in no higher rate of infection among its schoolchildren than in neighboring Finland, where schools did temporarily close, their public health agencies said in a joint report. Sweden decided to forego a hard lockdown and keep most schools and businesses open throughout the COVID-19 outbreak, a divisive strategy that set it apart from most of Europe. Its Public Health Agency has maintained that the negative consequences of a shutdown on the economy and society outweigh the benefits, and says this also applies to schools. During the period of February 24 to June 14, there were 1,124 confirmed cases of COVID-19 among children in Sweden, around 0.05% of the total number of children aged 1-19. Finland recorded 584 cases in the same period, also equivalent to around 0.05%. “In conclusion, (the) closure or not of schools had no measurable direct impact on the number of laboratory confirmed cases in school-aged children in Finland or Sweden,” the agencies said in the report. Sweden’s death toll of 5,572, when compared relative to population size, far outstripped those of its Nordic neighbors, although it remains lower than in some European countries that locked down, such as Britain and Spain. State epidemiologist Anders Tegnell of the health agency, who has devised Sweden’s response to the epidemic, has said there is little evidence linking the death toll to the absence of a lockdown.
Note: Explore an excellent article on Sweden's underreported success in dealing with COVID-19. For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.
The Centers for Disease Control and Prevention is conflating the results of two different types of coronavirus tests, distorting several important metrics and providing the country with an inaccurate picture of the state of the pandemic. We’ve learned that the CDC is making, at best, a debilitating mistake: combining test results that diagnose current coronavirus infections with test results that measure whether someone has ever had the virus. The agency confirmed to The Atlantic on Wednesday that it is mixing the results of viral and antibody tests, even though the two tests reveal different information and are used for different reasons. This is not merely a technical error. The upshot is that the government’s disease-fighting agency is overstating the country’s ability to test people who are sick with COVID-19. States have set quantitative guidelines for reopening their economies based on these flawed data points. Several states - including Pennsylvania, the site of one of the country’s largest outbreaks, as well as Texas, Georgia, and Vermont - are blending the data in the same way. Virginia likewise mixed viral and antibody test results until last week, but it reversed course and the governor apologized for the practice. These results damage the public’s ability to understand what is happening in any one state. On a national scale, they call the strength of America’s response to the coronavirus into question. The number of tests conducted nationwide each day has more than doubled in the past month. At the same time, the portion of tests coming back positive has plummeted.
Most new Covid-19 hospitalizations in New York state are from people who were staying home and not venturing much outside, a “shocking” finding, Gov. Andrew Cuomo said. The preliminary data was from 100 New York hospitals involving about 1,000 patients. It shows that 66% of new admissions were from people who had largely been sheltering at home. The next highest source of admissions was from nursing homes, 18%. Cuomo said nearly 84% of the hospitalized cases were people who were not commuting to work through car services, personal cars, public transit or walking. He said a majority of those people were either retired or unemployed. Overall, some 73% of the admissions were people over age 51. He said the information shows that those who are hospitalized are predominantly from the downstate area in or around New York City, are not working or traveling and are not essential employees. He also said a majority of the cases in New York City are minorities, with nearly half being African American or Hispanic. Cuomo said the state’s hospitalization rate has continued to decline, although at a “painfully slow” rate. He said around 600 infected people were still walking through hospital doors every day, although that number has also declined. While data shows the coronavirus is on the decline in New York, the new survey results appear to clash with Cuomo’s prior assurances that isolation can reliably prevent transmission.
Coronavirus patients without symptoms aren’t driving the spread of the virus, World Health Organization officials said Monday, casting doubt on concerns by some researchers that the disease could be difficult to contain due to asymptomatic infections. Preliminary evidence from the earliest outbreaks indicated that the virus could spread from person-to-person contact, even if the carrier never develops symptoms. But WHO officials now say that while asymptomatic spread can occur, it is not the main way it’s being transmitted. “From the data we have, it still seems to be rare that an asymptomatic person actually transmits onward to a secondary individual,” Dr. Maria Van Kerkhove, head of WHO’s emerging diseases and zoonosis unit, said. The virus is primarily spread via respiratory droplets when someone coughs or sneezes or if they touch a contaminated surface, scientists say. WHO officials say Covid-19 can also spread in the so-called pre-symptomatic stage — a few days before a patient shows symptoms. More research and data are needed to “truly answer” the question of whether the coronavirus can spread widely through asymptomatic carriers, Van Kerkhove added. “We have a number of reports from countries who are doing very detailed contact tracing,” she said. “They’re following asymptomatic cases. They’re following contacts. And they’re not finding secondary transmission onward. It’s very rare.”
Note: This official was immediately pressured to retract what she said, even though it was based on scientific studies. Learn in this Science magazine article how Fauci based his recommendations on one faulty study with five people to state "There's no doubt after reading this paper that asymptomatic transmission is occurring." See this CNN article for Fauci quote. For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.
Social isolation is a growing epidemic — one that’s increasingly recognized as having dire physical, mental and emotional consequences. Since the 1980s, the percentage of American adults who say they’re lonely has doubled from 20 percent to 40 percent. About one-third of Americans older than 65 now live alone, and half of those over 85 do. People in poorer health — especially those with mood disorders like anxiety and depression — are more likely to feel lonely. Those without a college education are the least likely to have someone they can talk to about important personal matters. A wave of new research suggests social separation is bad for us. Individuals with less social connection have disrupted sleep patterns, altered immune systems, more inflammation and higher levels of stress hormones. One recent study found that isolation increases the risk of heart disease by 29 percent and stroke by 32 percent. Another analysis that pooled data from 70 studies and 3.4 million people found that socially isolated individuals had a 30 percent higher risk of dying in the next seven years, and that this effect was largest in middle age. Loneliness can accelerate cognitive decline in older adults, and isolated individuals are twice as likely to die prematurely as those with more robust social interactions. These effects start early: Socially isolated children have significantly poorer health 20 years later. All told, loneliness is as important a risk factor for early death as obesity and smoking.
Note: For more along these lines, see concise summaries of deeply revealing news articles on health from reliable major media sources.
Sending children back to schools and day care centres in Denmark, the first country in Europe to do so, did not lead to an increase in coronavirus infections, according to official data, confirming similar findings from Finland on Thursday. As countries across Europe make plans to exit months of lockdown aimed at curbing the virus outbreak, some parents worry that opening schools first might put the health of their children in danger. Following a one-month lockdown, Denmark allowed children between two to 12 years back in day cares and schools on April 15. Based on five weeks' worth of data, health authorities are now for the first time saying the move did not make the virus proliferate. "You cannot see any negative effects from the reopening of schools," Peter Andersen, doctor of infectious disease epidemiology and prevention ... said on Thursday. In Finland, a top official announced similar findings on Wednesday, saying nothing so far suggested the coronavirus had spread faster since schools reopened in mid-May. The number of infected children aged between one and up to 19 has declined steadily since late April, Andersen said, following a slight uptick immediately after the reopening of schools. But this was too early to have anything to do with the reopening, he said. "Based on preliminary experiences, it does not look like there has been a negative effect on the spread among school children or in the society in general," Andersen said and called Denmark's reopening strategy "prudent". A steady drop in daily infections, hospital admissions and deaths since early April has led Denmark to continue its reopening, with shopping malls, bars, restaurants allowed to reopen in May.
Since June 19, when new cases in the United States went back over 30,000 in one day, we have been constantly bombarded with stories of how the virus is “spiking” in “record” numbers in many of the states (like California, Texas, Florida and Arizona) that were not hit hard in the “first wave.” Across the country, our number of new cases has indeed exploded to new levels during this time period ... and the news media, both at the national and local levels, have used these statistics to essentially create panic porn. The resulting public anxiety has caused several states to reverse their reopenings. Obviously the “new case” data point is both real and relevant, but it is also now extremely misleading. By incompetently using the same measure of what a “positive” virus test meant in April, to what it now means in July, the news media is in the process of, quite effectively, sabotaging America’s recovery from this crisis. The data ... now makes it overwhelmingly obvious that nowhere near as many people who recently tested positive for the virus are going to die as did when this nightmare began. While the development has gotten scandalously little news coverage, the daily numbers of deaths with/of COVID has been declining with remarkable consistency for well over two months now. Sweden, a country much maligned in the media because they dared to not lock down by government mandate, has “new case” and “death” charts which look remarkably similar to ours. Their daily death rate has recently been down to single digits.
Note: Don't miss this entire article which pulls back the curtain on media manipulations in these challenging times. For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus and media manipulation from reliable major media sources.
Dr. Richard Bartlett works at various clinics around West Texas, and says he’s found a successful treatment for the coronavirus. “The treatment plan is inhaled, generic budesonide,” Bartlett said. “Using some generic antibiotics to protect from a secondary bacterial infection. Using zinc, which interferes with virus replication. It’s common sense. It’s intuitive.” Budesonide is a steroid, that can be inhaled directly to the lungs using a nebulizer. The drug has been used for decades to treat asthma and is approved by the FDA. However using it to treat COVID-19 is not. “I am not aware of any doctors anywhere that are using this specifically for COVID-19, yet,” Bartlett said. Bartlett said he treats people as soon as they show symptoms. “Early treatment is better with this disease,” he said. “And I’m having a 100% survival rate. I don’t even know how many I’ve treated...dozens. I have 14 that I’m treating right now.” Bartlett said that patients tell him they feel immediate relief. Bartlett said he’s currently writing a paper to submit to medical journals. Additionally, he said the National Institute of Health, as well as the countries of France and Spain will be looking into inhaled budesonide treatments.
Note: Watch a fascinating interview with this doctor. And remember that the biggest sponsor of the major media is big Pharma. The don't want any cheap medicine like hydrochlorequine or budesonide to look good. There are other inexpensive treatments that are not being reported. For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.
The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries. Gilead Sciences announced the price Monday for remdesivir, and said the price would be $3,120 for patients with private insurance. The amount that patients pay out of pocket depends on insurance, income and other factors. The price was swiftly criticized; a consumer group called it “an outrage” because of the amount taxpayers invested toward the drug's development. In 127 poor or middle-income countries, Gilead is allowing generic makers to supply the drug; two countries are doing that for around $600 per treatment course. The drug, given through an IV, interferes with the coronavirus’s ability to copy its genetic material. In a U.S. government-led study, remdesivir shortened recovery time by 31% — 11 days on average versus 15 days for those given just usual care. Peter Maybarduk, a lawyer at the consumer group Public Citizen, called the price “an outrage.” “Remdesivir should be in the public domain” because the drug received at least $70 million in public funding toward its development, he said. “The price puts to rest any notion that drug companies will ‘do the right thing’ because it is a pandemic,” Dr. Peter Bach, a health policy expert ... said. “The price might have been fine if the company had demonstrated that the treatment saved lives. It didn’t.”
Note: The March coronavirus package passed in the U.S. "not only omitted language that would have limited drug makers’ intellectual property rights, it specifically prohibited the federal government from taking any action if it has concerns that the treatments or vaccines developed with public funds are priced too high." While many suffer economically from the virus, big Pharma is raking in big bucks. For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption and the coronavirus from reliable major media sources.
Sweden's state epidemiologist Anders Tegnell has hit back at the World Health Organization after it included Sweden in a group of countries facing "a very significance resurgence" of coronavirus infections. Mr Tegnell, who has in recent months become one of the world's most high profile and divisive epidemiologists, said: "That is, unfortunately, a total misinterpretation of the data." "It's very unfortunate that people lump Sweden together with countries that earlier have had no problem at all and are now apparently at the start of their epidemic," he told Sweden's state broadcaster SVT. Hans Kluge, the WHO's Regional Director for Europe, on Thursday named Sweden in a list of eleven problem countries ... which are facing "accelerated transmission" of infection. Sweden has this month seen the daily number of confirmed cases more than triple from 60 on June 1st to 207 on Thursday. But Mr Tegnell argued that this has to do with increased testing rather than a resurgence in infection. "This is growing because we recently started offering tests to everyone with symptoms," he told Sweden's TT newswire. "We are doing twice as many tests as we were a few weeks ago. But the growth we are seeing is in mild cases, not hospital admissions." Mr Tegnell has drawn both admiration and criticism internationally for leading a coronavirus strategy that left schools for 14-16 year olds open throughout the pandemic, as well as bars, restaurants, gyms, and much else, relying instead on the public's willingness to follow social distancing guidelines.
Hundreds of articles in medical journals claiming to be written by academics or doctors have been penned by ghostwriters in the pay of drug companies, an Observer inquiry reveals. The journals, bibles of the profession, have huge influence on which drugs doctors prescribe and the treatment hospitals provide. But The Observer has uncovered evidence that many articles written by so-called independent academics may have been penned by writers working for agencies which receive huge sums from drug companies to plug their products. Estimates suggest that almost half of all articles published in journals are by ghostwriters. While doctors who have put their names to the papers can be paid handsomely for 'lending' their reputations, the ghostwriters remain hidden. In the United States a legal case brought against drug firm Pfizer turned up internal company documents showing that it employed a New York medical writing agency. One document analyses articles about the anti-depressant Zoloft. Some of the articles lacked only one thing: a doctor's name. In the margin the agency had put the initials TBD, which Healy assumes means 'to be determined'. Dr Richard Smith, editor of the British Journal of Medicine, admitted ghostwriting was a 'very big problem'. 'We are being hoodwinked by the drug companies. The articles come in with doctors' names on them and we often find some of them have little or no idea about what they have written,' he said.
Note: For more along these lines, see concise summaries of deeply revealing news articles on corruption in science from reliable major media sources.
Bayer will pay more than $10 billion to resolve thousands of lawsuits regarding claims that its Roundup herbicide causes cancer, the company announced. Monsanto, bought by Bayer in 2018, lost a lawsuit that same year brought by a school groundskeeper who claimed its weedkiller had caused his non-Hodgkin's lymphoma. Since then, thousands of U.S. lawsuits have been filed against the company. The settlement, however, does not contain an admission of wrongdoing or liability. Bayer will pay $8.8 billion to $9.6 billion to settle existing lawsuits and then another $1.25 billion that will cover any potential litigation in the future. Lawsuits allege that Monsanto ignored warnings that its herbicide contained potentially cancer causing chemicals, then concealed the threat to consumers. A jury awarded California groundskeeper Dewayne Johnson nearly $290 million in damages in August 2018 after they found Monsanto failed to warn Johnson and other consumers about the risks posed by its weed-killing products. A judge upheld the decision upon appeal, but lowered the damages to $78 million due to what she considered an overreach in punitive damages decided by the jury. And last year, a California jury awarded a husband and wife more than $2 billion in damages in a suit that claimed Roundup caused their illness. German pharmaceuticals and chemical giant Bayer bought Monsanto in 2018 just months before Johnson won his suit against the company. Bayer eliminated the Monsanto name, but maintained the brands.
Note: The negative health impacts of Roundup are well known. Yet the EPA continues to use industry studies to declare Roundup safe while ignoring independent scientists. For more along these lines, see concise summaries of deeply revealing news articles on health from reliable major media sources.
Important Note: Explore our full index to revealing excerpts of key major media news stories on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.